Trial · NCT02674750
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Median Progression-free Survival | Group A | 1.2 | 95% Confidence Interval 1.02 to 1.41 | months | |
| Median Progression-free Survival | Group B | 2.7 | 95% Confidence Interval 1.28 to 4.05 | months | |
| Median Progression-free Survival | Group C | 2.6 | 95% Confidence Interval 1.28 to 21.94 | months | |
| Overall Survival (OS) | Group A | 1 | participants | ||
| Overall Survival (OS) | Group B | 17 | participants | ||
| Overall Survival (OS) | Group C | 2 | participants | ||
| Disease Control Rate (DCR) | Group A | 0.0 | 95% Confidence Interval 0.00 to 84.19 | percentage of participants | |
| Disease Control Rate (DCR) | Group B | 46.4 | 95% Confidence Interval 27.51 to 66.13 | percentage of participants | |
| Disease Control Rate (DCR) | Group C | 44.4 | 95% Confidence Interval 13.70 to 78.80 | percentage of participants | |
| Number of Participants and Severity of Adverse Events (AEs), Serious Adverse Events (SAEs), and Other Safety Parameters | CUDC-907 | Experienced at least 1 TEAE | 68 | participants | |
| Number of Participants and Severity of Adverse Events (AEs), Serious Adverse Events (SAEs), and Other Safety Parameters | CUDC-907 | Experienced at least 1 study tx-related TEAE | 59 | participants | |
| Number of Participants and Severity of Adverse Events (AEs), Serious Adverse Events (SAEs), and Other Safety Parameters | CUDC-907 | Experienced a Grade <3 TEAE | 52 | participants | |
| Number of Participants and Severity of Adverse Events (AEs), Serious Adverse Events (SAEs), and Other Safety Parameters | CUDC-907 | Experienced a Grade <3 TEAE tx-related | 34 | participants | |
| Number of Participants and Severity of Adverse Events (AEs), Serious Adverse Events (SAEs), and Other Safety Parameters | CUDC-907 | Experienced at least 1 tx emergent SAE | 30 | participants | |
| Number of Participants and Severity of Adverse Events (AEs), Serious Adverse Events (SAEs), and Other Safety Parameters | CUDC-907 | Experienced a TEAE with outcome of death | 17 | participants | |
| Number of Participants and Severity of Adverse Events (AEs), Serious Adverse Events (SAEs), and Other Safety Parameters | CUDC-907 | Experienced a TEAE leading to D/C | 11 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02674750/results